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Elevated serum uric acid levels are associated with a variety of adverse health outcomes, including gout, hypertension, 
diabetes mellitus, metabolic syndrome, and cardiovascular diseases. Several genome-wide association studies on uric acid 
levels have implicated the ATP-binding cassette, subfamily G, member 2 (ABCG2) gene as being possibly causal. We 
investigated an association between the single-nucleotide polymorphism (SNP) rs2725220 in the ABCG2 gene and uric acid 
levels in the Korean population. A total of 991 subjects in Seoul City were used for a replication study with ABCG2 SNP 
rs2725220. The rs2725220 SNP in the ABCG2 gene was associated with mean uric acid levels (effect per allele 0.25 mg/dL, p 
＜ 0.0001). Subjects with the GC/CC genotype had a 1.78-fold (range, 1.22- to 2.62-fold) higher risk of having abnormal uric 
acid levels (≥7.0 mg/dL) than subjects with the GG genotype. When analyzed by gender, the association with ABCG2 was 
stronger in men than in women. The association with ABCG2 was much stronger in male subjects with body mass index (BMI) 
≥ 26.4 (odds ratio, 5.09; 95% confidence interval, 2.41 to 10.8) than in male subjects with BMI ＜ 26.4. This study clearly 
demonstrates that genetic variations in ABCG2 influence uric acid levels in Korean adults.
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Introduction
Elevated serum uric acid levels are associated with a 
variety of adverse health outcomes, including gout, hyper-
tension, diabetes mellitus, metabolic syndrome, and cardio-
vascular diseases [1]. Several genome-wide association 
studies (GWASs) have identified genes that may be causally 
associated with uric acid levels, including the ATP-binding 
cassette, subfamily G, member 2 (ABCG2) gene (MIM 
603756) [2-7]. Replication studies of ABCG2 variants have 
been performed in Western and Asian countries [8, 9]. 
Okada et al. [4] identified a significant association between 
the rs2725220 single-nucleotide polymorphism (SNP) on 
chromosome 4q22 and uric acid levels.
The ABCG2 protein is a high-capacity transporter for uric 
acid excretion in the kidney, liver, and gut [10, 11]. In this 
study, we analyzed the relationship between uric acid levels 
and the ABCG2 SNP rs2725220 using a group of volunteers 
from the Korean Metabolic Syndrome Research Initiative 
Study in Seoul. We also analyzed the association of the 




Subjects for the GWAS were recruited from the Korean 
Metabolic Syndrome Research Initiative Study in Seoul City, 
which was initiated in December 2005. A total of 9,128 
individuals were recruited in 2006, and an additional 17,569 
individuals were recruited in 2007 [12-14]. Therefore, the 
total Seoul City cohort included 26,697 volunteers. Volun-
teers from the first round underwent routine health 
examinations at the health promotion centers in university 
hospitals between January 2006 and December 2007. From 
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Table 1. General characteristics of the study population
Subjects Subjects in Seoul City
No. 991
Male gender (%) 56.3
Age (y) 41.5 ± 8.5
Waist circumference (cm) 81.1 ± 9.7
Body mass index (kg/m2) 23.7 ± 3.1
Fasting blood sugar (mg/dL) 93.8 ± 16.4
Systolic blood pressure (mm Hg) 120.8 ± 13.8
Diastolic blood pressure (mm Hg) 73.8 ± 10.4
HDL-cholesterol (mg/dL) 54.2 ± 12.9
LDL-cholesterol (mg/dL) 108.7 ± 29.2
Triglyceride (mg/dL) 118.0 ± 93.5
Uric acid (mg/dL) 5.34 ± 1.50
Smoking status Non-smoker 549 (55.4)
Ex-smoker 166 (16.7)
Current smoker 276 (27.9)
Uric acid (mg/dL) Normal (＜7.0) 845 (85.3)
Abnormal (≥7.0) 146 (14.7)
Values are presented as mean ± standard deviation or number 
(%).
HDL, high-density lipoprotein; LDL, low-density lipoprotein.
this total, 6,563 individuals were randomly selected for 
measurement of adiponectin levels. The subject charac-
teristics were described in a previous study [14]. In brief, of 
the 6,563 individuals whose adiponectin was measured, 
1,004 individuals were genotyped. The 1,004 subjects were 
all healthy individuals and were not undergoing any 
treatment for hyperuricemia. The Institutional Review 
Board of Human Research of Yonsei University approved the 
protocols of this study, and written informed consent was 
obtained from all subjects prior to enrollment.
Data collection
Participants were interviewed using a structured que-
stionnaire to collect a personal history of cigarette smoking 
(never smoked, ex-smoker, or current smoker) and demo-
graphic characteristics (age, gender, etc.). Waist circum-
ference was measured midway between the lower rib and 
iliac crest. For measurements of weight and height, light 
clothing was worn. Body mass indices were calculated as the 
subject’s weight (kg) divided by the square of the subject’s 
height (m2).
For clinical chemistry assays, serum was separated from 
peripheral venous blood samples obtained from each parti-
cipant after a 12-hour fast and stored at –70oC. Biomarkers of 
metabolic syndrome, including fasting blood glucose, total 
cholesterol, triglycerides, and high-density lipoprotein 
cholesterol, and uric acid levels were measured. Quality 
control of the data was conducted in accordance with the 
procedures recommended by the Korean Association of 
Laboratory Quality Control.
Genotyping assays
Samples from the Seoul City cohort were genotyped on 
the Affymetrix Genome-Wide Human SNP Array 5.0 
(Affymetrix Inc., Santa Clara, CA, USA) at DNALink. For the 
data obtained from this chip, internal quality control (QC) 
measures were used: the QC call rate (Dynamic Model 
algorithm) always exceeded 86%. Genotype calling was 
carried out using the Birdseed (v2) algorithm. A total of 
1,004 individuals were genotyped using this platform. Ten of 
the 1,004 individuals were removed due to low genotyping 
call rates (＜95%). Three individuals were excluded due to 
failed genotyping of rs2725220, leaving a total of 991 
individuals for the study. 
Statistical analysis
Data were expressed as means ± standard deviation (SD). 
Most statistical analyses were performed using PLINK and 
SAS (version 9.2; SAS Institute, Cary, NC, USA). The ABCG2 
gene SNP rs2725220 was selected using the Affymetrix 
Genomewide Human SNP Array 5.0.
Each SNP was tested for possible effects on uric acid levels 
under an additive model. The multivariate linear regression 
models used in the study incorporated covariates (age and 
sex). Multiple logistic regression analysis was also perform-
ed. Odds ratios (ORs) with 95% confidence intervals (CIs) 
were calculated to examine the association of the ABCG2 
SNP with abnormal uric acid levels (≥7 mg/dL for men and 
≥6 mg/dL for women). All statistical tests were two-sided, 
and the statistical significance was determined as p ＜ 0.05.
Results
The majority of individuals in this study was middle-aged 
(Table 1). This sample of Korean volunteers had low uric acid 
levels on average. Mean levels of uric acid in the dataset were 
higher in males (6.23 mg/dL) than in females (4.21 mg/dL). 
The percentage of individuals with abnormal uric acid levels 
(≥7.0 mg/dL) was 14.7% for the Seoul City sample. The 
percentage of current smokers in the Seoul City dataset was 
46.4% among male subjects and 3.9% among female 
subjects.
Table 2 shows the p-values from a linear regression model 
for uric acid levels in the cohort sample, with age and sex 
included as covariates in the model. The rs2725220 SNP in 
the ABCG2 gene was found to be associated with mean uric 
acid levels (effect per allele 0.25 mg/dL, p ＜ 0.0001), which 
was significant after Bonferroni correction (p = 0.00025). 
The minor allele frequency of rs2725220 was 0.222, and 
Hardy-Weinberg equilibrium was satisfied (p = 0.7079).
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Table 2. Association of ABCG2 gene SNP rs2725220 with uric acid levels and lipid levels based on a linear regression model
Phenotype
Genotype (mean ± SD) Effect
(mg/dL) p-value*GG (n = 601) GC (n = 340) CC (n = 50)
Uric acid (mg/dL) 5.26 ± 1.39 5.41 ± 1.59 5.93 ± 1.94 0.25 ＜0.0001
HDL-cholesterol (mg/dL) 53.6 ± 12.6 55.5 ± 13.3 52.7 ± 12.9 0.71   0.2631
Triglyceride (mg/dL) 117.9 ± 85.2 115.0 ± 94.5 138.9 ± 159.9 3.46   0.4679
LDL-cholesterol (mg/dL) 108.9 ± 29.5 107.8 ± 28.4 113.9 ± 31.2 0.77   0.6179
Estimated effect size () and p-value in the multiple linear regression model considering age and sex under an additive model.
SNP, single-nucleotide polymorphism; SD, standard deviation; HDL, high-density lipoprotein; LDL, low-density lipoprotein.
Table 3. Odds ratio (OR) of polymorphic genotypes of ABCG2 gene SNP rs2725220 on uric acid levelsa in Seoul City data (n = 991)
Subject Genotype
Normal (＜7.0 mg/dL)b Abnormal (≥7.0 mg/dL)b
No. (%) No. (%) OR (95% CI) p-value
All GG 527 (62.4) 74 (50.7) 1.00 (reference)
GC/CC 318 (37.6) 72 (49.3) 1.78 (1.22–2.62) 0.0031
Men GG 269 (65.1) 73 (50.3) 1.00 (reference)
GC/CC 144 (34.9) 72 (49.7) 1.82 (1.24–2.68) 0.0023
Women GG 253 (60.2)  6 (46.2) 1.00 (reference)
GC/CC 167 (39.8)  7 (53.8) 1.75 (0.58–5.31) 0.3215
SNP, single-nucleotide polymorphism; CI, confidence interval. 
aAdjusted for age and sex; bAbnormal (≥6.0 mg/dL) and normal (＜6.0 mg/dL) were used for women.
Table 4. Odds ratio (OR) of polymorphic genotypes of ABCG2 gene SNP rs2725220 on uric acid levelsa in Korean men (n = 558)
Subject Genotype
Normal (＜7.0 mg/dL) Abnormal (≥7.0 mg/dL)
No. (%) No. (%) OR (95% CI) p-value
BMI (kg/m2) ＜22.65 GG 72 (62.6) 13 (54.2) 1.00 (reference)
GC/CC 43 (37.4) 11 (45.8) 1.41 (0.58–3.43) 0.4456
＜24.3 GG 71 (64.0) 13 (44.8) 1.00 (reference)
GC/CC 40 (36.0) 16 (55.2) 2.13 (0.93–4.89) 0.0748
＜26.4 GG 63 (60.0) 25 (71.4) 1.00 (reference)
GC/CC 42 (40.0) 10 (28.6) 0.60 (0.26–1.38) 0.2263
≥26.4 GG 63 (76.8) 22 (38.6) 1.00 (reference)
GC/CC 19 (23.2) 35 (61.4) 5.09 (2.41–10.8) ＜0.0001
WC (cm) ＜80 GG 71 (64.0) 10 (55.6) 1.00 (reference)
GC/CC 40 (36.0)  8 (44.4) 1.42 (0.52–3.89) 0.4956
＜86 GG 73 (61.3) 15 (48.4) 1.00 (reference)
GC/CC 46 (38.7) 16 (51.6) 1.68 (0.76–3.74) 0.2016
＜91 GG 65 (69.2) 17 (51.5) 1.00 (reference)
GC/CC 29 (30.8) 16 (48.5) 1.98 (0.87–4.54) 0.1054
≥91 GG 60 (67.4) 31 (49.2) 1.00 (reference)
GC/CC 29 (32.6) 32 (50.8) 2.10 (1.08–4.10) 0.0299
SNP, single-nucleotide polymorphism; CI, confidence interval; BMI, body mass index; WC, waist circumference. 
aAdjusted for age.
We also analyzed the association of rs2725220 with 
abnormal uric acid levels (Table 3). Subjects with the GC/CC 
genotype had a 1.78-fold (range, 1.22- to 2.62-fold) higher 
risk of having abnormal uric acid levels (≥7.0 mg/dL) than 
subjects with the GG genotype. When analyzed by gender, 
the association with ABCG2 was stronger in men than in 
women. In Table 4, we analyzed the association of ABCG2 by 
body mass index (BMI) quartile levels and waist circum-
ference quartile levels in male subjects. The association with 
ABCG2 was much stronger in male subjects with BMI ≥ 
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26.4 (OR, 5.09; 95% CI, 2.41 to 10.8) than in male subjects 
with BMI ＜ 26.4. The association with ABCG2 was also a 
little bit stronger in male subjects with waist circumference 
(WC) ≥ 91 (OR, 2.10; 95% CI, 1.08 to 4.10) than in male 
subjects with WC ＜ 91.
Discussion
In a cohort study of 991 subjects, an ABCG2 gene SNP was 
associated with increased uric acid, consistent with previous 
studies. Several GWASs have reported that ABCG2 exerts a 
major influence on uric acid levels [2, 3, 6, 7]. Dehghan et al. 
[6] conducted a genomewide study in which an SNP in the 
ABCG2 gene, rs2231142, displayed strong evidence of an 
association with uric acid levels (p ＜ 10–60). Another GWAS 
also reported that rs2231142 showed a strong association 
with uric acid levels (p = 5.1 × 10–6) [2]. More recently, a 
GWAS in European-American obesity cases and controls 
reported significant genome-wide association of two SNPs 
with uric acid levels: rs2622605 and rs1481017 [3]. Another 
recent GWAS also reported a strong association between 
rs2231142 and uric acid levels (p = 3.34.1 × 10–42) [7].
In the present study, rs2725220 was found to have a 
strong association with uric acid levels. In agreement with 
these findings, a recent study reported that rs2725220 was 
strongly associated with uric acid levels (effect per allele 
–0.135 mg/dL, p = 4.2 × 10–30) [4]. Several recent studies 
reported that the association between serum uric acid and 
the allelic effects of SNPs in ABCG2 was sex-specific [8, 9]. 
In a recent study of 4 US populations, the association 
between rs2231142 and serum uric acid was significantly 
stronger in men and postmenopausal women compared to 
their premenopausal counterparts [9]. In the present study, 
the association of the ABCG2 gene SNP with uric acid was 
stronger in men than in women.
Associations between genotypes and phenotypes can be 
modified by gene-environment interactions. A modification 
of the effect of the associations between ABCG2 SNPs and 
serum uric acid concentrations by interactions with obesity 
has been reported [3, 9]. In a recent study of 4 US 
populations, the association between rs2231142 and serum 
uric acid was stronger in normal-weight subjects than in 
obese subjects [9]. In the present study, we also examined 
the association of the ABCG2 SNP with uric acid levels 
according to BMI level and waist circumference. The 
association was stronger in subjects with a high BMI and 
high WC levels than in subjects with a low BMI and low WC 
levels. 
The ABCG2 gene encodes a membrane transporter 
belonging to the ATP-binding cassette superfamily of mem-
brane transporters, a group involved in the trafficking of 
biological molecules across cell membranes. The ABCG2 
gene contains 16 exons and spans over 66 kb [15]. Allikmets 
et al. [16] mapped the ABCG2 gene to human chromosome 
4q22 using radiation hybrid analysis.
Candidate gene analysis suffers from population sub-
structure. We estimated the identity by state over all SNPs, 
and only four individuals were shown to be biological 
relatives. Genetic studies in Asian populations may not 
identify the same set of genes as those in European 
populations [17]. Nevertheless, the Seoul City cohort study 
in Korean populations indicates that the ABCG2 gene on 
chromosome 4 is associated with serum uric acid levels, as is 
the case in several other populations.
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